Literature DB >> 21178126

Chronic estradiol exposure induces oxidative stress in the hypothalamus to decrease hypothalamic dopamine and cause hyperprolactinemia.

Sheba M J MohanKumar1, Badrinarayanan S Kasturi, Andrew C Shin, Priya Balasubramanian, Ebony T Gilbreath, Madhan Subramanian, Puliyur S Mohankumar.   

Abstract

Estrogens are known to cause hyperprolactinemia, most probably by acting on the tuberoinfundibular dopaminergic (TIDA) system of the hypothalamus. Dopamine (DA) produced by TIDA neurons directly inhibits prolactin secretion and, therefore, to stimulate prolactin secretion, estrogens inhibit TIDA neurons to decrease DA production. However, the mechanism by which estrogen produces this effect is not clear. In the present study, we used a paradigm involving chronic exposure to low levels of estradiol-17β (E(2)) to mimic prolonged exposures to environmental and endogenous estrogens. We hypothesized that chronic exposure to low levels of E(2) induces oxidative stress in the arcuate nucleus (AN) of the hypothalamus that contains TIDA neurons and causes nitration of tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of DA. This results in a significant decrease in DA and consequently, hyperprolactinemia. To investigate this, adult, intact female cycling rats were implanted with slow-release E(2) pellets (20 ng/day) for 30, 60, or 90 days and were compared with old (16-18 mo old) constant estrous (OCE) rats. Chronic E(2) exposure significantly increased the expression of glial fibrillary acidic protein and the concentrations of interleukin-1β (IL-1β) and nitrate in the AN that contains perikarya of TIDA neurons and increased nitration of TH in the median eminence (ME) that contains the terminals. These levels were comparable to those seen in OCE rats. We observed a significant decrease in DA concentrations in the ME and hyperprolactinemia in an exposure-dependent manner similar to that seen in OCE rats. It was concluded that chronic exposure to low levels of E(2) evokes oxidative stress in the AN to inhibit TIDA neuronal function, most probably leading to hyperprolactinemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21178126      PMCID: PMC3064273          DOI: 10.1152/ajpregu.00481.2010

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  45 in total

1.  Neuroendocrine status of old constant-estrous rats.

Authors:  J A Clemens; J Meites
Journal:  Neuroendocrinology       Date:  1971       Impact factor: 4.914

2.  Combination of inflammatory cytokines increases nitrite and nitrate levels in the paraventricular nucleus of conscious rats.

Authors:  T Wakita; F Shintani; G Yagi; M Asai; S Nozawa
Journal:  Brain Res       Date:  2001-06-29       Impact factor: 3.252

3.  Postmenopausal estrogen replacement therapy and risk of AD: a population-based study.

Authors:  S C Waring; W A Rocca; R C Petersen; P C O'Brien; E G Tangalos; E Kokmen
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

Review 4.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

5.  Evidence for a permanent decline in tuberoinfundibular dopaminergic neuronal function after chronic estrogen treatment is terminated in Fischer 344 rats.

Authors:  P E Gottschall; J Meites
Journal:  Neuroendocrinology       Date:  1986       Impact factor: 4.914

6.  Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat.

Authors:  J R Brawer; F Naftolin; J Martin; C Sonnenschein
Journal:  Endocrinology       Date:  1978-08       Impact factor: 4.736

7.  Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA.

Authors:  J P O'Callaghan
Journal:  Neurotoxicol Teratol       Date:  1991 May-Jun       Impact factor: 3.763

8.  The reaction of no with superoxide.

Authors:  R E Huie; S Padmaja
Journal:  Free Radic Res Commun       Date:  1993

9.  Chronic exposure to low levels of oestradiol-17beta affects oestrous cyclicity, hypothalamic norepinephrine and serum luteinising hormone in young intact rats.

Authors:  B S Kasturi; S M J MohanKumar; M P Sirivelu; P S MohanKumar
Journal:  J Neuroendocrinol       Date:  2009-06       Impact factor: 3.627

10.  Effect of intracerebroventricular injection of lipopolysaccharide on the tuberoinfundibular dopaminergic system of the rat.

Authors:  M C González; P Abreu; P Barroso-Chinea; I Cruz-Muros; T González-Hernández
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  10 in total

1.  Ghrelin mediates stress-induced food-reward behavior in mice.

Authors:  Jen-Chieh Chuang; Mario Perello; Ichiro Sakata; Sherri Osborne-Lawrence; Joseph M Savitt; Michael Lutter; Jeffrey M Zigman
Journal:  J Clin Invest       Date:  2011-06-23       Impact factor: 14.808

2.  Sex differences in the pituitary transforming growth factor-β1 system: studies in a model of resistant prolactinomas.

Authors:  M Victoria Recouvreux; Lara Lapyckyj; M Andrea Camilletti; M Clara Guida; Ana Ornstein; Daniel B Rifkin; Damasia Becu-Villalobos; Graciela Díaz-Torga
Journal:  Endocrinology       Date:  2013-09-05       Impact factor: 4.736

3.  Chronic estrogen exposure affects gene expression in the rostral ventrolateral medulla of young and aging rats: Possible role in hypertension.

Authors:  Madhan Subramanian; Coral Hahn-Townsend; Kimberly A Clark; Sheba M J MohanKumar; P S MohanKumar
Journal:  Brain Res       Date:  2015-09-12       Impact factor: 3.252

4.  Chronic estradiol-17β exposure suppresses hypothalamic norepinephrine release and the steroid-induced luteinizing hormone surge: role of nitration of tyrosine hydroxylase.

Authors:  Badrinarayanan S Kasturi; Sheba M J MohanKumar; Madhu P Sirivelu; Andrew C Shin; P S Mohankumar
Journal:  Brain Res       Date:  2012-11-26       Impact factor: 3.252

Review 5.  Protective actions of 17β-estradiol and progesterone on oxidative neuronal injury induced by organometallic compounds.

Authors:  Yasuhiro Ishihara; Takuya Takemoto; Atsuhiko Ishida; Takeshi Yamazaki
Journal:  Oxid Med Cell Longev       Date:  2015-03-01       Impact factor: 6.543

6.  Chronic exposure to low doses of estradiol-17ß increases blood pressure in young female rats: A possible role for central Endothelin-1.

Authors:  Madhan Subramanian; Sheba M J MohanKumar; Priya Balasubramanian; Carrie A Northcott; Hannah Garver; Gregory D Fink; P S MohanKumar
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

7.  Long-Term l-Serine Administration Reduces Food Intake and Improves Oxidative Stress and Sirt1/NFκB Signaling in the Hypothalamus of Aging Mice.

Authors:  Xihong Zhou; Haiwen Zhang; Liuqin He; Xin Wu; Yulong Yin
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-23       Impact factor: 5.555

8.  State of hormonal balance in adolescent girls with menstrual function disorders associated with obesity.

Authors:  Alla Volodymyrivna Borshuliak; Oksana Anatoliivna Andriiets; Oksana Valerianivna Bakun; Anatolii Volodymyrovich Andriiets; Volodymyr Vasyliovich Andriiets; Michael Ivanovicha Sheremet; Valentin Nicolae Varlas
Journal:  J Med Life       Date:  2021 Nov-Dec

9.  Unveiling the Metabolic Profile of First-Episode Drug-Naïve Schizophrenia Patients: Baseline Characteristics of a Longitudinal Study Among Han Chinese.

Authors:  Qi Zhang; Hui He; Xia Bai; Liping Jiang; Wei Chen; Xiaoying Zeng; Yanjia Li; Antonio L Teixeira; Jing Dai
Journal:  Front Psychiatry       Date:  2021-07-09       Impact factor: 4.157

Review 10.  Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Stefano Fais; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.